Translation News and Research

RSS

LSI announces success of Pro Bono Program to educate foster parents on child health

Linguistic Systems, Inc. (LSI), a leading provider of language translation services, is proud to announce the success of the LSI Foundation's Pro Bono Program, providing translation and interpreting services to those organizations serving the community, and specifically enabling LSI employees to give back to their community. The LSI staff has seen the difference the program has made for local organizations and has decided to increase their contributions through the fall.

12 Aug 2010

Tengion announces clinical, corporate and second-quarter financial updates

Tengion Inc. today provided a corporate and product development update and reported its financial results for the quarter ended June 30, 2010.

12 Aug 2010

Needle-free natural vaccine against malaria: Research

A study published in the journal Science Translational Medicine proposes that preventative treatment with affordable and safe antibiotics in people living in areas with intense malaria transmission has the potential to act as a 'needle-free' natural vaccine against malaria and may likely provide an additional valuable tool for controlling and/or eliminating malaria in resource-poor settings.

12 Aug 2010

Quality of translations of clinical trial consent forms questioned

The first study to look at simplified English-language consent forms translated into another language calls into question the common belief that a translated consent form meets readability standards. The study appears in IRB: Ethics & Human Research.

11 Aug 2010

New optical imaging technique holds potential to improve angioplasty

A new optical imaging technique described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics, holds the potential to greatly improve angioplasty, a surgery commonly performed to treat patients with a partially or completely blocked coronary artery that restricts blood flow to the heart.

11 Aug 2010

SMI/Omega development team receives fund to develop prototype fast multispectral endoscope

Cascade Technologies, Inc., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will receive NIH research funding through a collaboration with Omega Optical of Brattleboro, Vermont. This effort will accelerate development of a new class of medical endoscopes enhanced with proprietary multispectral imaging technology. The principal investigators on the project are Dr. Gary Carver, Director of Research at Omega Optical, and Dr. Daniel L. Farkas, Chairman and CEO of SMI.

11 Aug 2010

Language Line University offers new scalable online training tool for medical interpreters

Language Line(R) University, the interpreter assessment and training division of Language Line Services, an over-the-phone and video interpretation services provider, is offering a new scalable online training tool for medical interpreters. LLU Web Advanced Medical Training for Interpreters, the first of its kind in the industry, combines 15 hours of self-paced Web activities with 10 hours of live over-the-phone instructor-led sessions. Completion of the course qualifies participants to receive 10 continuing education points from the American Translators Association.

10 Aug 2010

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.

10 Aug 2010

Scientists identify role of PNPASE in regulating RNA import into mitochondria

Researchers at UCLA's Jonsson Comprehensive Cancer Center and the departments of Chemistry and Biochemistry and Pathology and Laboratory Medicine have uncovered a role for an essential cell protein in shuttling RNA into the mitochondria, the energy-producing "power plant" of the cell. The import of nucleus-encoded small RNAs into mitochondria is essential for the replication, transcription and translation of the mitochondrial genome, but the mechanisms that deliver RNA into mitochondria remain poorly understood.

7 Aug 2010

WaferGen launches SmartChip System for discovery, validation of biomarkers

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced it has launched the breakthrough WaferGen SmartChip Real-Time PCR System, the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform. The SmartChip System is designed to provide accurate, highly sensitive and high-throughput gene expression profiling capabilities to researchers, clinicians and pharmaceutical companies.

6 Aug 2010

Alnylam second-quarter revenues increase to $26.6 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2010, and company highlights.

5 Aug 2010

Siteman Cancer Center to test radiotherapy system from ViewRay

Researchers at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, a national leader in the early adoption and use of advanced treatments for cancer patients, will soon become the first in the world to test an innovative radiotherapy system from ViewRay, Inc. The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of medical imaging and radiotherapy delivery.

4 Aug 2010

West Pharmaceutical Services second-quarter gross profit increases 5.8% to $83.2 million

West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.

3 Aug 2010

OCM announces findings from Diagnostic Management Program

One Call Medical, the nation's leading provider of diagnostic testing (including MRI and CT scans) and specialty services (e.g. transportation and translation), today announced findings from its Diagnostic Management Program, revealing that on average, a typical workers' compensation payer may have as much as two-thirds of its diagnostic radiology referrals go "unmanaged," leading to overpayments, inefficiencies, and quality issues in the diagnostic referral, scheduling, and results process.

3 Aug 2010

Charles River Laboratories International second-quarter 2010 net sales decline 5.2%

Charles River Laboratories International, Inc. today reported its results for the second quarter of 2010. For the quarter, net sales were $292.1 million, a decline of 5.2% from $308.2 million in the second quarter of 2009. Foreign currency translation reduced the sales growth rate by 0.1%. A modest sales increase in the Research Models and Services segment was offset by lower sales for the Preclinical Services segment.

2 Aug 2010

Aetna offers two RHP plans for companies in need of health care cover

Companies operating across the Middle East now have a new choice in health benefits plans from Aetna Global Benefits (AGB), the international business segment of Aetna, that provides additional flexibility in cover and affordability. The organisation has expanded its Regional Healthcare Plan (RHP) for companies in need of health care cover for their expatriate employees living across the region.

2 Aug 2010

Mylan second-quarter adjusted diluted EPS increases to $0.37

Mylan Inc. today announced its financial results for the three and six months ended June 30, 2010.

29 Jul 2010

Bruker second-quarter adjusted EPS grows 114% y-o-y to $0.15

Bruker Corporation today reported financial results for the three and six months ended June 30, 2010.

28 Jul 2010

Waters second-quarter 2010 sales increase 8% to $391 million

Waters Corporation reported today second quarter 2010 sales of $391 million, an increase of 8% over sales of $363 million in the second quarter of 2009. These quarterly sales include an adverse foreign currency translation impact of approximately 1%. On a GAAP basis, earnings per diluted share for the second quarter were $0.90, compared to $0.72 for the second quarter in 2009.

28 Jul 2010

Aflac second-quarter total revenues increase 15.5% to $5.0 billion

Reflecting the benefit from a stronger yen/dollar exchange rate and lower realized investment losses, total revenues rose 15.5% to $5.0 billion in the second quarter of 2010, compared with $4.3 billion in the second quarter of 2009. Net earnings were $581 million, or $1.23 per diluted share, compared with $314 million, or $.67 per share, a year ago.

28 Jul 2010